Evidence map›Paper›PMID 33301527›Full record

ArticlePLoS pathogens2020

Long-term persistence of infectious Zika virus: Inflammation and behavioral sequela in mice.

Derek D C Ireland, Mohanraj Manangeeswaran, Aaron P Lewkowicz, Kaliroi Engel, Sarah M Clark, Adelle Laniyan, Jacob Sykes, Ha-Na Lee, Ian L McWilliams, Logan Kelley-Baker and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Flaviviruses-Induced Neurological Sequelae.Pathogens (Basel, Switzerland) · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Derek D C IrelandUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0001-5829-4206
Mohanraj ManangeeswaranUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0002-4021-9352
Aaron P LewkowiczUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0002-3272-7816
Kaliroi EngelUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0003-1016-7528
Sarah M ClarkUniversity of Maryland School of Medicine, Department of Psychiatry, Baltimore, Maryland, United States of America.ORCID 0000-0001-7328-0726
Adelle LaniyanUniversity of Maryland School of Medicine, Department of Psychiatry, Baltimore, Maryland, United States of America.ORCID 0000-0001-6821-8565
Jacob SykesUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0002-0520-4796
Ha-Na LeeUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.
Ian L McWilliamsUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0003-0621-6112
Logan Kelley-BakerUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0003-4411-2058
Leonardo H TonelliUniversity of Maryland School of Medicine, Department of Psychiatry, Baltimore, Maryland, United States of America.
Daniela VerthelyiUS Food and Drug Administration, Office of Biotechnology Products, Silver Spring, Maryland, United States of America.ORCID 0000-0002-5450-3071
United States Food and Drug Administration · USUniversity of Maryland, Baltimore · US

Funding

University of Maryland Center of Excellence in Regulatory Science and InnovationU01FD005946 · FDA · UNIV OF MARYLAND, COLLEGE PARK · PI BENTLEY, WILLIAM E., POLLI, JAMES E · 2016 to 2025
$21.5M
FDA HHS U01 FD005946
6 · The paper itself

Abstract

The neurodevelopmental defects associated with ZIKV infections early in pregnancy are well documented, however the potential defects and long-term consequences associated with milder infections in late pregnancy and perinatal period are less well understood. To model these, we challenged 1 day old (P1) immunocompetent C57BL/6 mice with ZIKV. The animals developed a transient neurological syndrome including unsteady gait, kinetic tremors, severe ataxia and seizures 10-15 days post-infection (dpi) but symptoms subsided after a week, and most animals survived. Despite apparent recovery, MRI of convalescent mice show reduced cerebellar volume that correlates with altered coordination and motor function as well as hyperactivity and impulsivity. Persistent mRNA levels of pro-inflammatory genes including Cd80, Il-1α, and Ifn-γ together with Cd3, Cd8 and perforin (PrfA), suggested persistence of low-grade inflammation. Surprisingly, the brain parenchyma of convalescent mice harbor multiple small discrete foci with viral antigen, active apoptotic processes in neurons, and cellular infiltrates, surrounded by activated astrocytes and microglia as late as 1-year post-infection. Detection of negative-sense strand viral RNA and isolation of infectious virus derived from these convalescent mice by blinded passage in Vero cells confirmed long-term persistence of replicating ZIKV in CNS of convalescent mice. Although the infection appears to persist in defined reservoirs within CNS, the resulting inflammation could increase the risk of neurodegenerative disorders. This raises concern regarding possible long-term effects in asymptomatic children exposed to the virus and suggests that long-term neurological and behavioral monitoring as well as anti-viral treatment to clear virus from the CNS may be useful in patients exposed to ZIKV at an early age.

Indexed as

AnimalsBrainChlorocebus aethiopsDisease Models, AnimalFemaleInflammationMiceMice, Inbred C57BLMicrocephalyNeuronsPregnancyPregnancy Complications, InfectiousVero CellsZika VirusZika Virus Infection

Identifiers

PMID33301527
PMCPMC7728251
OpenAlexW3112508849

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.